Sign Up
Stories
Accelus Strengthens Leadership with New Board Appointments
Share
Bone Grafts and Substitutes Market Growt...
Growing Markets in Healthcare Technology
Innovative ZAP-X Revolutionizes Brain Tr...
Apple's Vision Pro Revolutionizes Surgic...
Artificial Disc Market Set for Rapid Exp...
Chronic Pain Treatment Market Set to Gro...
Overview
API
Accelus, a medical technology company, has appointed two new board members, Kevin McGann and Bernie Haffey, to strengthen its leadership. McGann, the current President and CEO, has been instrumental in the company's growth and success, while Haffey brings a proven track record in executive leadership. Accelus's Adaptive Geometry technology, including its flagship product, the FlareHawk® Interbody Fusion System, is gaining global attention. The company is focused on expanding its interbody portfolio and offers complementary products to enhance surgical procedures and patient outcomes.
Ask a question
How has Kevin McGann contributed to Accelus's growth and success?
What are the key features of Accelus's Adaptive Geometry technology?
What are the potential benefits of Accelus's interbody portfolio expansion?
Article Frequency
0.2
0.4
0.6
0.8
1.0
Nov 2023
Dec 2023
Jan 2024
Coverage